Christopher R. Fenimore is SVP Finance & CFO of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 14,372 shares of REGN, which is worth approximately $16.6 Million. The most recent transaction as insider was on Feb 09, 2024, when has been sold 4,919 shares (Common Stock) at a price of $952.92 per share, resulting in proceeds of $4,687,413. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.4K
0% 3M change
31.37% 12M change
Total Value Held $16.6 Million

Christopher R. Fenimore Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 09 2024
SELL
Open market or private sale
$4,687,413 $952.92 p/Share
4,919 Reduced 25.5%
14,372 Common Stock
Jan 23 2024
SELL
Payment of exercise price or tax liability
$7,179,196 $948.5 p/Share
7,569 Reduced 28.18%
19,291 Common Stock
Jan 23 2024
BUY
Exercise of conversion of derivative security
$4,776,600 $477.66 p/Share
10,000 Added 30.42%
22,874 Common Stock
Jan 03 2024
SELL
Payment of exercise price or tax liability
$6,853,197 $912.3 p/Share
7,512 Reduced 30.82%
16,860 Common Stock
Jan 03 2024
BUY
Exercise of conversion of derivative security
$4,776,600 $477.66 p/Share
10,000 Added 32.97%
20,329 Common Stock
Dec 27 2023
SELL
Open market or private sale
$2,097,226 $856.71 p/Share
2,448 Reduced 14.55%
14,372 Common Stock
Dec 22 2023
SELL
Open market or private sale
$211,567 $846.27 p/Share
250 Reduced 1.46%
16,820 Common Stock
Dec 21 2023
SELL
Open market or private sale
$1,417,819 $843.94 p/Share
1,680 Reduced 8.96%
17,070 Common Stock
Dec 12 2023
SELL
Payment of exercise price or tax liability
$2,186,323 $856.71 p/Share
2,552 Reduced 11.98%
18,750 Common Stock
Dec 11 2023
SELL
Payment of exercise price or tax liability
$1,296,522 $844.09 p/Share
1,536 Reduced 6.73%
21,302 Common Stock
Dec 08 2023
SELL
Payment of exercise price or tax liability
$399,956 $843.79 p/Share
474 Reduced 2.26%
20,468 Common Stock
Dec 08 2023
BUY
Grant, award, or other acquisition
-
2,370 Added 9.4%
22,838 Common Stock
Aug 23 2023
SELL
Payment of exercise price or tax liability
$4,380,146 $842.66 p/Share
5,198 Reduced 19.89%
20,942 Common Stock
Aug 23 2023
BUY
Exercise of conversion of derivative security
$2,797,620 $399.66 p/Share
7,000 Added 21.12%
26,140 Common Stock
Mar 23 2023
SELL
Open market or private sale
$1,767,782 $806.47 p/Share
2,192 Reduced 10.64%
18,409 Common Stock
Feb 03 2023
SELL
Payment of exercise price or tax liability
$2,544,316 $774.29 p/Share
3,286 Reduced 13.93%
20,295 Common Stock
Feb 03 2023
BUY
Exercise of conversion of derivative security
$1,352,150 $270.43 p/Share
5,000 Added 17.49%
23,581 Common Stock
Dec 16 2022
BUY
Grant, award, or other acquisition
-
1,926 Added 9.39%
18,581 Common Stock
Dec 09 2022
SELL
Payment of exercise price or tax liability
$186,060 $753.28 p/Share
247 Reduced 1.46%
16,655 Common Stock
Oct 05 2022
SELL
Open market or private sale
$1,381,156 $749.0 p/Share
1,844 Reduced 10.09%
16,425 Common Stock
Oct 03 2022
SELL
Open market or private sale
$2,422,504 $724.0 p/Share
3,346 Reduced 15.48%
18,269 Common Stock
Apr 08 2022
SELL
Payment of exercise price or tax liability
$4,127,193 $736.21 p/Share
5,606 Reduced 17.4%
26,615 Common Stock
Apr 08 2022
BUY
Exercise of conversion of derivative security
$3,077,222 $413.05 p/Share
7,450 Added 19.86%
30,066 Common Stock
Mar 31 2022
SELL
Payment of exercise price or tax liability
$6,066,367 $700.99 p/Share
8,654 Reduced 25.89%
24,771 Common Stock
Mar 31 2022
BUY
Exercise of conversion of derivative security
$4,956,600 $413.05 p/Share
12,000 Added 27.51%
31,628 Common Stock
CRF

Christopher R. Fenimore

SVP Finance & CFO
Tarrytown, NY

Track Institutional and Insider Activities on REGN

Follow REGENERON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN